Drug Shortage Report for HYDROMORPH CONTIN-CONTROLLED RELEASE CAP - 18MG

Last updated on 2020-12-01 History
Report ID 127123
Drug Identification Number 02243562
Brand name HYDROMORPH CONTIN-CONTROLLED RELEASE CAP - 18MG
Common or Proper name NHYDROMORPH CONTIN
Company Name PURDUE PHARMA
Market Status MARKETED
Active Ingredient(s) HYDROMORPHONE HYDROCHLORIDE
Strength(s) 18MG
Dosage form(s) CAPSULE (SUSTAINED-RELEASE)
Route of administration ORAL ORAL
Packaging size 60
ATC code N02AA
ATC description OPIOIDS
Reason for shortage Delay in shipping of the drug.
Anticipated start date 2020-11-06
Actual start date 2020-11-16
Estimated end date 2020-11-30
Actual end date 2020-11-26
Shortage status Resolved
Updated date 2020-12-01
Company comments
Health Canada comments
Contact Address 575 GRANITE COURT
PICKERING, ONTARIO
CANADA L1W 3W8
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v8 2020-12-01 French Compare
v7 2020-12-01 English Compare
v6 2020-11-20 French Compare
v5 2020-11-20 English Compare
v4 2020-11-07 English Compare
v3 2020-10-26 English Compare
v2 2020-10-26 French Compare
v1 2020-10-26 English Compare